Zdrowie i gospodarka · 13/07/2022

FDA Clears REGLAN Injection for Continued Sale

The US Food and Drug Administration (FDA) has determined that REGLAN Injection, a medication equivalent to 5mg or 10mg per milliliter, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market and enabling the FDA to approve new abbreviated new drug applications (ANDAs) that reference this product.